Comparison of Iodixanol and Iohexol in Patients Undergoing Intravenous Pyelography: A Prospective Controlled Study

REFERENCES

• Lindholt JS. Radiocontrast induced nephropathy. Eur J Vasc Endovasc Surg. 2003; 25: 296–304
   PubMed Web of Science ®Google Scholar
• McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997; 103: 368–375
   PubMed Web of Science ®Google Scholar
• Anto HR, Chou SY, Porush JG, Shapiro WB. Infusion intravenous pyelography and renal function. Effect of hypertonic mannitol in patients with chronic renal insufficiency. Arch Intern Med. 1981; 141: 1652–1656
   PubMedGoogle Scholar
• Rao SR, Mieza MA, Leiter E. Renal failure in diabetes after intravenous urography. Urology. 1980; 15: 577–580
   PubMedGoogle Scholar
• Berg KJ. Nephrotoxicity related to contrast media. Scand J Urol Nephrol. 2000; 34: 317–322
   PubMed Web of Science ®Google Scholar
• Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int. 1994; 45: 259–265
   PubMed Web of Science ®Google Scholar
• Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: A prospective controlled study. N Engl J Med. 1989; 320: 143–149
   PubMed Web of Science ®Google Scholar
• Taliercio CP, Vlietstra RE, Ilstrup DM, et al. A randomized comparison of the nephrotoxity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. J Am Coll Cardiol. 1991; 17: 384–390
   PubMedGoogle Scholar
• Moore RD, Steinberg EP, Powe NR, et al. Nephrotoxity of high-osmolality versus low-osmolality contrast media: Randomized clinical trial. Radiology. 1992; 182: 649–655
   PubMedGoogle Scholar
• Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995; 47: 254–261
   PubMed Web of Science ®Google Scholar
• Schwab SJ, Hlatky MA, Pieper KS, et al. Contrast nephrotoxicity: A randomized controlled trial of a nonionic and ionic radiographic contrast agent. N Engl J Med. 1989; 320: 149–153
   PubMed Web of Science ®Google Scholar
• Barrett BJ, Parfrey PS, Vavasour HM, et al. Contrast nephropathy in patients with impaired renal function: High versus low osmolar media. Kidney Int. 1992; 41: 1274–1279
   PubMed Web of Science ®Google Scholar
• Nicot GS. Transient glomerular proteinuria, enzymuria, and nephrotoxic reaction induced by radiocontrast media. JAMA. 1984; 252: 2432–2434
   PubMed Web of Science ®Google Scholar
• Tervahartiala P, Kivisaari L, Kivisaari R, Virtanen I. Contrast media-induced renal morphologic lesions in diabetic rats. Acta Radiol. 1993; 34: 220–225
   PubMedGoogle Scholar
• Yoshioka T, Fogo A, Beckman JK. Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int. 1992; 41: 1008–1015
   PubMed Web of Science ®Google Scholar
• Bakris GL, Lass NA, Glock D. Renal hemodynamics in radiocontrast medium induced renal dysfunction: A role for dopamine-1 receotors. Kidney Int. 1999; 56: 206–210
   PubMed Web of Science ®Google Scholar
• Liss P, Nygren A, Erikson U, Ulfendahl HR. Injection of low and iso-osmolar contrast media decreases oxygen tension in the renal media. Kidney Int. 1998; 35: 698–702
   Google Scholar
• Anarat A, Duman N, Noyan A, Kibar M, Anarat R. The role of endothelin in radiocontrast nephropathy. Int Urol Nephrol. 1997; 29: 609–613
   PubMedGoogle Scholar
• Hizoh I, Haller C. Radiocontrast-induced renal tubular cell apoptosis: Hypertonic versus oxidative stress. Invest Radiol. 2002; 37: 428–434
   PubMed Web of Science ®Google Scholar
• Beaufils H, Idee JM, Berthommier C, et al. Iobitridol, a new nonionic low-osmolality contrast agent, and iohexol: Impact on renal histology in the rat. Invest Radiol. 1995; 30: 33–39
   PubMedGoogle Scholar
• Gyoten M. Activation of the complement system and cytokine production by radiographic contrast media in vascular endothelial cells in vitro. Nippon Igaku Hoshasen Gakkai Zasshi. 1998; 58: 811–815, [in Japanese]
   PubMedGoogle Scholar
• Bohm I, Speck U, Schild H. Cytokine profiles after nonionic dimeric contrast medium injection. Invest Radiol. 2003; 38: 776–783
   PubMedGoogle Scholar
• Nishibori M, Kohka-Takahashi H, Mori S. Regulation of cytokine production by histamine through H2-receptor stimulation. Nippon Yakurigaku Zasshi-Folia Pharmacologica Japonica. 2001; 118: 29–35
   PubMedGoogle Scholar
• Robertson PW, Frewin DB, Robertson AR, et al. Plasma histamine levels following administration of radiographic contrast media. Br J Radiol. 1985; 58: 1047–1051
   PubMedGoogle Scholar
• Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: Randomized comparison of two hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002; 162: 329–336
   PubMed Web of Science ®Google Scholar
• Erley CM, Duda SH, Rehfuss D, et al. Prevention of radiocontrast-media-induced nephropathy in patient with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant. 1999; 14: 1146–1149
   PubMed Web of Science ®Google Scholar
• Koch JA, Plum J, Grabansee B, Modder U. Prostaglandin E1: A new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media?. Nephrol Dial Transplant. 2000; 15: 43–49
   PubMed Web of Science ®Google Scholar
• Lehnert T, Keller E, Gondolf K, Schaffner T, Pavenstadt H, Schollmeyer P. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Trasplant. 1998; 13: 358–362
   PubMed Web of Science ®Google Scholar
• Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: Analysis of date from reports to the U.S. Food and Drug Administration. Radiology. 1997; 203: 605–610
   PubMed Web of Science ®Google Scholar
• Moore RD, Steinberg EP, Powe NR, et al. Frequency and determinants of adverse reactions induced by high-osmolality contrast media. Radiology. 1989; 170: 727–732
   PubMedGoogle Scholar
• Rydberg J, Charles J, Aspelin P. Frequency of late allergy-like adverse reactions following injection of intravascular non-ionic contrast media. Acta Radiol. 1998; 39: 219–222
   PubMedGoogle Scholar
• Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br Radiol. 1999; 72: 701–703
   PubMed Web of Science ®Google Scholar
• Harkonen S, Kjellstrand CM. Exacerbation of diabetic renal failure following intravenous pyelography. Am J Med. 1977; 63: 939–946
   PubMed Web of Science ®Google Scholar
• Wolf GL, Arenson RL, Cross AP. A prospective trial of ionic vs. nonionic contrast agents in routine clinical practice: Comparison of adverse effect. AJR 1989; 152: 939–944
   PubMedGoogle Scholar
• Sogn EE, Ødegård T, Haider T, et al. Adverse reactions following two separate intravascular injections of contrast media in the same patient. Acta Radiol. 1987; 28: 93–97
   PubMedGoogle Scholar
• Panto PN, Davies P. Delayed reactions to urographic contrast media. Br J Radiol. 1986; 59: 41–44
   PubMedGoogle Scholar
• Sutton AGC, Finn P, Grech ED, et al. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catherization. Am Heart J. 2001; 141: 677–683
   PubMedGoogle Scholar
• Christiansen C, Pichler WJ, Skotland T. Delayed allergy-like reactions to x-ray contrast media: Mechanistic considerations. Eur Radiol. 2000; 10: 1965–1975
   PubMedGoogle Scholar
• Kanzaki T, Sakagami H. Late phase allergic reaction to a CT contrast medium (iotrolan). J Dermatol. 1991; 18: 528–531
   PubMedGoogle Scholar